coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection

RxCUI
2108128
RxNorm name
coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection
Display name
coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection
Full name
coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125586AndexxaCoagulation Factor Xa (Recombinant), Inactivated-zhzo351(a)Disc2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ANDEXXAANDEXANET ALFAAstraZeneca Pharmaceuticals LP2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c2025-05-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2108128

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2d9d90a6-63e6-46ef-96ff-dd6519ae7b6ccoagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [PSN] · coagulation factor Xa (recombinant), inactivated-zhzo 200 MG Injection [SCD]27These highlights do not include all the information needed to use ANDEXXA safely and effectively. See Full Prescribing Information for ANDEXXA. ANDEXXA ® (coagulation factor Xa (recombinant), inactivated-zhzo) Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 201820250523